Highly Efficient Synthesis of New 3,5-Substituted (Isoxazolines) and 2,3,5-Trisubstituted (Pyrazolines) Mediated by Chloramin-T and Their Evaluation of Antioxidant and Antibacterial Activities

被引:1
作者
Musad, Ebraheem Abdu [1 ]
Al Dawsari, Abdullah Mohammed [1 ]
Abdalla, Zaki Eldin Ali [1 ]
Husain, Kakul [1 ]
Al Sharabi, Razaz Saeed Saeed [2 ]
Rai, K. M. Lokanatha [3 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Arts & Sci, Dept Chem, Wadi Al Dawasir 11991, Saudi Arabia
[2] Prince Sattam Bin Abdulaziz Univ, Coll Sci & Humanities, Dept Math, Slayel, Saudi Arabia
[3] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India
关键词
isoxazolines; pyrazolines; Chloramine-T; antioxidant; antibacterial; NITRILE OXIDES; ANTIMICROBIAL ACTIVITY; DERIVATIVES; GENERATION;
D O I
10.1134/S1068162020050180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two short series of five membered heterocyclic 3,5-disubstituted-isoxazolines derivatives (Va-f) and 2,3,5-trisubstituted-pyrazolines derivatives (VIIa-f) were synthesized via 1,3-dipolar cycloaddition reaction of 2-(allyloxy)-4,6-dimethoxypyrimidine (III) with aromatic aldoximes (IV) which undergo oxidative-dehydrogenation with Chloramine-T to give 3,5-disubstituted-isoxazolines derivatives (Va-f) and oxidative cyclization of diphenyl hydrazones (VI) using Chloramine-T to give 2,3,5-trisubstituted-pyrazoline derivatives (VIIa-f) in good yield. The newly synthesized compounds were screened for anti-oxidant and anti-microbial activities. 2,3,5-trisubstituted-pyrazolines derivatives (VIIb-e) revealed higher antioxidant activity at 10 mu g/mL while 3,5-disubstituted-isoxazolines derivatives (Va-c) and 2,3,5-trisubstituted-pyrazolines derivatives (VIIa-c) showed better anti-microbial activity at 100 mu g/mL compared with standard vitamin C and ciprofloxacin, respectively. Structures of newly synthesized compounds were established on the basis of their elemental analysis and spectral IR, H-1-NMR and C-13-NMR.
引用
收藏
页码:814 / 821
页数:8
相关论文
共 26 条
[1]  
Al-Mulla A., 2017, Der. Pharma. Chemica, V9, P141, DOI DOI 10.1016/J.RECHEM.2022.100606
[2]   BSAC standardized disc susceptibility testing method (version 7) [J].
Andrews, J. M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (02) :256-278
[3]  
Angew H.R., 1963, CHEM INT ED, V2, P565, DOI [10.1002/anie.196305651, DOI 10.1002/ANIE.196305651]
[4]   Solution-phase synthesis of novel Δ2-isoxazoline libraries via 1,3-dipolar cycloaddition and their antifungal properties [J].
Basappa ;
Sadashiva, MP ;
Mantelingu, K ;
Swamy, SN ;
Rangappa, KS .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) :4539-4544
[5]   ANTIOXIDANT DETERMINATIONS BY THE USE OF A STABLE FREE RADICAL [J].
BLOIS, MS .
NATURE, 1958, 181 (4617) :1199-1200
[6]  
Caramella P., 1984, 1 3 DIPOLAR CYCLOADD
[7]   The pyrrole moiety as a template for COX-1/COX-2 inhibitors [J].
Dannhardt, G ;
Kiefer, W ;
Krämer, G ;
Maehrlein, S ;
Nowe, U ;
Fiebich, B .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (05) :499-510
[8]   Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities [J].
Fahmy, Hoda H. ;
Khalifa, Nagy M. ;
Ismail, Magda M. F. ;
El-Sahrawy, Hend M. ;
Nossier, Eman S. .
MOLECULES, 2016, 21 (03)
[9]   ISOXAZOLINE DERIVATIVES AS POTENTIAL INHIBITORS OF THE PROTEOLYTIC-ENZYMES HUMAN-LEUKOCYTE ELASTASE, CATHEPSIN-G AND PROTEINASE-3 - A STRUCTURE-ACTIVITY RELATIONSHIP STUDY [J].
GROUTAS, WC ;
VENKATARAMAN, R ;
CHONG, LS ;
YODER, JE ;
EPP, JB ;
STANGA, MA ;
KIM, EH .
BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (02) :125-128
[10]  
HASSNER A, 1989, SYNTHESIS-STUTTGART, P57